1. Home
  2. MSA vs MDGL Comparison

MSA vs MDGL Comparison

Compare MSA & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSA
  • MDGL
  • Stock Information
  • Founded
  • MSA 1914
  • MDGL 2011
  • Country
  • MSA United States
  • MDGL United States
  • Employees
  • MSA N/A
  • MDGL N/A
  • Industry
  • MSA Industrial Specialties
  • MDGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSA Health Care
  • MDGL Health Care
  • Exchange
  • MSA Nasdaq
  • MDGL Nasdaq
  • Market Cap
  • MSA 6.5B
  • MDGL 6.1B
  • IPO Year
  • MSA N/A
  • MDGL N/A
  • Fundamental
  • Price
  • MSA $174.27
  • MDGL $345.73
  • Analyst Decision
  • MSA Buy
  • MDGL Strong Buy
  • Analyst Count
  • MSA 5
  • MDGL 9
  • Target Price
  • MSA $188.20
  • MDGL $421.63
  • AVG Volume (30 Days)
  • MSA 194.8K
  • MDGL 444.2K
  • Earning Date
  • MSA 08-04-2025
  • MDGL 08-05-2025
  • Dividend Yield
  • MSA 1.21%
  • MDGL N/A
  • EPS Growth
  • MSA 2.08
  • MDGL N/A
  • EPS
  • MSA 7.01
  • MDGL N/A
  • Revenue
  • MSA $1,827,831,000.00
  • MDGL $515,547,000.00
  • Revenue This Year
  • MSA $2.98
  • MDGL $286.67
  • Revenue Next Year
  • MSA $5.21
  • MDGL $67.98
  • P/E Ratio
  • MSA $24.90
  • MDGL N/A
  • Revenue Growth
  • MSA 0.55
  • MDGL 3421.98
  • 52 Week Low
  • MSA $127.86
  • MDGL $200.63
  • 52 Week High
  • MSA $187.41
  • MDGL $377.46
  • Technical
  • Relative Strength Index (RSI)
  • MSA 48.59
  • MDGL 66.79
  • Support Level
  • MSA $173.30
  • MDGL $286.44
  • Resistance Level
  • MSA $182.86
  • MDGL $350.00
  • Average True Range (ATR)
  • MSA 3.65
  • MDGL 15.23
  • MACD
  • MSA -0.62
  • MDGL 3.77
  • Stochastic Oscillator
  • MSA 14.48
  • MDGL 93.28

About MSA MSA Safety Incorporated

MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The products include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems. End markets include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company's reportable geographic segments are Northern North America; Latin America; Europe, Middle East & Africa; and Asia Pacific. The company's operating segments have been aggregated into three reportable segments: Americas, International, and Corporate. Geographically the company generates the majority of its revenue from the United States.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: